Ultrasound image features of intravesical prostatic protrusion indicated failure of medication therapy of finasteride and doxazosin in patients with benign prostatic hyperplasia (LUTS/BPH)

被引：0
|
作者：
Qiang Liu
Yunkai Zhu
Jianping Liu
Jun Qi
Jian Kang
机构：
[1] Shanghai Jiao Tong University School of Medicine,Department of Urology, Xinhua Hospital
[2] Shanghai Jiao Tong University School of Medicine,Department of Ultrasonography, Xinhua Hospital
[3] Nantong Rich Hospital,Department of Radiology
来源：
International Urology and Nephrology | 2017年 / 49卷
关键词：
Intravesical prostatic protrusion; International Prostatic Symptom Score; Benign prostatic hyperplasia; Ultrasound; Urodynamics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：399 / 404
页数：5
相关论文
共 50 条
  • [31] COMPARISON OF POSTOPERATIVE OUTCOMES ACCORDING TO INTRAVESICAL PROSTATIC PROTRUSION IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA WHO UNDERWENT HOLMIUM LASER ENUCLEATION OF THE PROSTATE
    Yoo, E. S.
    Chung, J.
    Ha, Y.
    Choi, S. H.
    Lee, J. N.
    Kim, B. S.
    Kim, H. T.
    Kim, T.
    Kwon, T. G.
    Chung, S. K.
    Seo, Y. J.
    NEUROUROLOGY AND URODYNAMICS, 2017, 36 : S259 - S259
  • [32] Pre-surgical finasteride therapy in patients treated endoscopically for benign prostatic hyperplasia
    Crea, G
    Sanfilippo, G
    Anastasi, G
    Magno, C
    Vizzini, C
    Inferrera, A
    UROLOGIA INTERNATIONALIS, 2005, 74 (01) : 51 - 53
  • [33] MAINTENANCE OF CLINICAL EFFICACY WITH FINASTERIDE THERAPY FOR 24 MONTHS IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA
    STONER, E
    ARCHIVES OF INTERNAL MEDICINE, 1994, 154 (01) : 83 - 88
  • [34] Impact of COVID-19 vaccination on lower urinary tract (LUTS) in benign prostatic hyperplasia (BPH) patients
    Shamshirgaran, Amirreza
    Taheri, Diana
    Yahyazadeh, Seyed Reza
    Baghdadabad, Leila Zareian
    Zahmatkesh, Parisa
    Yar, Ehsan Zemanati
    Alaeddini, Farshid
    Khoshchehreh, Mahdi
    Mohammadi, Abdolreza
    Tavoosian, Ali
    Aghamir, Seyed Mohammad Kazem
    CLINICAL AND EXPERIMENTAL VACCINE RESEARCH, 2025, 14 (01) : 44 - 50
  • [35] Efficacy and tolerability of doxazosin and finasteride, alone or in combination, in treatment of symptomatic benign prostatic hyperplasia: The Prospective European Doxazosin and Combination Therapy (PREDICT) trial
    Kirby, RS
    Roehrborn, C
    Boyle, P
    Bartsch, G
    Jardin, A
    Cary, MM
    Sweeney, M
    Grossman, EB
    UROLOGY, 2003, 61 (01) : 119 - 126
  • [36] A TEMPORAL DIFFERENCE OBSERVED IN THE EFFECT OF DUTASTERIDE ON REDUCING PROSTATE VOLUME DEPENDS ON THE DEGREE OF INTRAVESICAL PROSTATIC PROTRUSION IN MALE PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA
    Suzuki, T.
    Otsuka, A.
    Furuse, H.
    Ozono, S.
    NEUROUROLOGY AND URODYNAMICS, 2015, 34 : S70 - S72
  • [37] Combination therapy with omega-3 fatty acids plus tamsulocin and finasteride in the treatment of men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH)
    Alireza Ghadian
    Mehran Rezaei
    Inflammopharmacology, 2017, 25 : 451 - 458
  • [38] Combination therapy with omega-3 fatty acids plus tamsulocin and finasteride in the treatment of men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH)
    Ghadian, Alireza
    Rezaei, Mehran
    INFLAMMOPHARMACOLOGY, 2017, 25 (04) : 451 - 458
  • [39] Time Course of Incident Adverse Experiences Associated with Doxazosin, Finasteride and Combination Therapy in Men with Benign Prostatic Hyperplasia: The MTOPS Trial
    Kaplan, Steven A.
    Lee, Jeannette Y.
    Meehan, Alan G.
    Kusek, John W.
    JOURNAL OF UROLOGY, 2016, 195 (06): : 1825 - 1829
  • [40] Switch from phytotherapy to tamsulosin in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH)
    Gross, AJ
    Busse, M
    Leonard, J
    Schumacher, H
    PROSTATE CANCER AND PROSTATIC DISEASES, 2005, 8 (03) : 210 - 214
12345